Trial Profile
Modulation of growth hormone action during growth hormone replacement in growth hormone-deficient women: comparison of raloxifene and oral oestrogen.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Raloxifene (Primary) ; Estradiol
- Indications Hypopituitarism
- Focus Pharmacodynamics
- 29 Aug 2011 New source identified and integrated (Australian New Zealand Clinical Trials Registry).
- 05 Nov 2010 New trial record.